Latest Content

Edward Choy, partner at Sho Eyeworks, shares success stories of private practices creating their own eyewear frame line.

Knowing what’s on the market for AMD and GA aids in preserving vision.

Evolutions in AI, myopia management, and individualized care are on ODs' minds for the new year.

The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials showing efficacy, according to the company.

Edward Choy, partner at Sho Eyeworks, advises practice owners on the fence of developing their own brand to dive in.

Telomere biology may link ocular aging and tissue dysfunction in the eye.

A recent study represents a step forward in investigations of the retinal layers as they are affected by glaucoma.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, discuss the company's price points and partner subscription options.

New drugs on the market and survey findings were among some of the top stories in dry eye from the past year.

An overview of the top 10 stories from eye care for 2025.

The researchers conducted a literature search of MEDLINE and Embase, PubMed, Cochrane Library, and Web of Sciences databases from 2003 to 2023.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, drive home the importance of profitability in creating an eyewear brand.

The PDUFA target action date is June 30, 2026.